SCHEDULE 13G/A

Ovid therapeutics, Inc.

Common Stock, par value $0.001 per share · CUSIP: 690469101

Event date: 2025-12-08

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Takeda Pharmaceutical Company Limited

  Shares: 8,781,996.00 · Class: 12.3%

• Takeda Pharmaceutical U.S.A., Inc.

  Shares: 7,000,000.00 · Class: 9.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.